• 中文版
  • BM
  • News
  • Deals
  • Reviews
    • First Impressions
    • Hands-on
    • Comparisons
  • Tech
    • Mobile
    • Computers
    • Cameras
    • Wearables
    • Audio
    • Drones
  • Telco
    • Celcom
    • Digi
    • Maxis
    • Time
    • U Mobile
    • Unifi
    • Yes
  • Video
  • Cars
  • Contribute
Menu
  • 中文版
  • BM
  • News
  • Deals
  • Reviews
    • First Impressions
    • Hands-on
    • Comparisons
  • Tech
    • Mobile
    • Computers
    • Cameras
    • Wearables
    • Audio
    • Drones
  • Telco
    • Celcom
    • Digi
    • Maxis
    • Time
    • U Mobile
    • Unifi
    • Yes
  • Video
  • Cars
  • Contribute
Search
  • 中文版
  • BM
  • News
  • Deals
  • Reviews
    • First Impressions
    • Hands-on
    • Comparisons
  • Tech
    • Mobile
    • Computers
    • Cameras
    • Wearables
    • Audio
    • Drones
  • Telco
    • Celcom
    • Digi
    • Maxis
    • Time
    • U Mobile
    • Unifi
    • Yes
  • Video
  • Cars
  • Contribute
Menu
  • 中文版
  • BM
  • News
  • Deals
  • Reviews
    • First Impressions
    • Hands-on
    • Comparisons
  • Tech
    • Mobile
    • Computers
    • Cameras
    • Wearables
    • Audio
    • Drones
  • Telco
    • Celcom
    • Digi
    • Maxis
    • Time
    • U Mobile
    • Unifi
    • Yes
  • Video
  • Cars
  • Contribute
Search
Close
Home News

Dr Noor Hisham: Pfizer COVID-19 vaccine gets conditional approval for booster shot 6 months after second dose

  • BY soyacincau
  • 8 October 2021
  • 6:48 pm
  • Comment
Share on FacebookShare on Twitter

The Health Ministry announced today that it has granted conditional approval for the Comirnaty vaccine manufactured by Pfizer-BioNTech to be used as a booster shot six months after the second dose.

Health director-general Tan Sri Dr Noor Hisham Abdullah said that the COVID-19 vaccine booster dose for those aged 18 and above was decided during the 365th meeting with Malaysia’s Drug Control Authority (DCA) earlier today.

“The meeting gave conditional approval for a booster dose of Pfizer’s COVID-19 vaccine, Comirnaty Concentrate for Dispersion for Injection (Comirnaty) produced by Pfizer Manufacturing Belgium NV (Belgium) and BioNTech Manufacturing GmbH, Germany, after at least six months of the second dose for those aged 18 and above,” he said in a statement today.

Pihak Berkuasa Kawalan Dadah memberi kelulusan bersyarat bagi pemberian dos penggalak (booster dose) vaksin COVID-19 Pfizer sekurang-kurangnya selepas 6 bulan dos kedua untuk golongan berumur 18 tahun dan ke atas. pic.twitter.com/fmyTTysFkB

— KKMalaysia🇲🇾 (@KKMPutrajaya) October 8, 2021

Dr Noor Hisham said that the Cominarty vaccine is the first to be approved for booster dose in Malaysia.

Previously, Dr Noor Hisham announced that Malaysia has given conditional approval for two new vaccine variants which need only one dose to be administered.

The vaccines are the Convidecia Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), produced by CanSino Biologics Inc, China, and the Janssen COVID-19 Vaccine from Johnson & Johnson.

Dr Noor Hisham announced that the Comirnaty vaccine produced by Pfizer-BioNTech has also been approved for use in those aged 12 and above. —  Malay Mail

[ IMAGE SOURCE ]

Tags: covid-19Covid-19 vaccineDr Noor Hisham AbdullahMalaysiaMinistry of Health
soyacincau

soyacincau

POPULAR

Here’s how much it costs to replace an EV tyre on the Kia EV6 in Malaysia

January 25, 2023

Dr Noor Hisham: Pfizer COVID-19 vaccine gets conditional approval for booster shot 6 months after second dose

October 8, 2021

Did you know that the new Enhanced TNG Card with NFC expires in 7 instead of 10 years?

January 30, 2023

Malaysian VFX artist turns KL into a zombie wasteland to promote The Last Of Us

January 25, 2023

Samsung Galaxy S23: Here’s the clearest look yet at Samsung’s 2023 flagship smartphones

January 23, 2023

Is this Malaysia’s first Apple Store?

January 27, 2023

Copyright © 2022 · SoyaCincau.com
Mind Blow Sdn Bhd (1076827-P)

  • ADVERTISE
  • DISCLAIMER

Copyright © 2022 · SoyaCincau.com – Mind Blow Sdn Bhd (1076827-P)

  • ADVERTISE
  • DISCLAIMER